{"id":1346,"date":"2014-12-11T13:47:22","date_gmt":"2014-12-11T13:47:22","guid":{"rendered":"http:\/\/www.wi.rwth-aachen.de\/SmartMedCN\/?p=1346"},"modified":"2014-12-11T13:47:22","modified_gmt":"2014-12-11T13:47:22","slug":"france-germany-suspend-some-drug-approvals-over-data-by-gvk-biosciences","status":"publish","type":"post","link":"https:\/\/blog.rwth-aachen.de\/smartmedcn\/2014\/12\/11\/france-germany-suspend-some-drug-approvals-over-data-by-gvk-biosciences\/","title":{"rendered":"France, Germany suspend some drug approvals over data by GVK Biosciences"},"content":{"rendered":"

Regulators in France, Germany, Belgium and Luxembourg are suspending the marketing approval of 25 generic drugs due to concerns over the quality of data from clinical trials conducted by India’s GVK Biosciences, French watchdog ANSM said on Friday. The quality of Indian pharmaceuticals has come under fire this year, with regulators in Europe and the United States citing problems ranging from data manipulation to sanitation and banning the import of certain products from several firms. (Source: The Ecnomic Times)<\/strong><\/p>\n

\u7978\u4e0d\u5355\u884c\uff0c\u6b27\u6d32\u56db\u56fd\u53d6\u6d88\u5370\u5ea6GVK\u00a0Biosciences25\u79cd\u4eff\u5236\u836f\u6388\u6743<\/h3>\n

\u6765\u6e90\uff1a\u751f\u7269\u8c37<\/p>\n

\u6838\u5fc3\u63d0\u793a\uff1a\u5370\u5ea6\u8fd1\u65e5\u7684\u5236\u836f\u4ea7\u4e1a\u53ef\u8c13\u662f\u4e00\u6ce2\u672a\u5e73\uff0c\u4e00\u6ce2\u53c8\u8d77\u3002\u7ee7\u7f8e\u56fd\u3001\u5fb7\u56fd\u56e0\u751f\u4ea7\u95ee\u9898\u7981\u6b62\u5176\u6297\u751f\u7d20\u8fdb\u53e3\u4e4b\u540e\uff0c\u8fd1\u65e5\u6cd5\u56fd\u3001\u5fb7\u56fd\u3001\u6bd4\u5229\u65f6\u548c\u5362\u68ee\u5821\u53d6\u6d88\u6279\u51c6\u5370\u5ea6GVK Biosciences\u768425\u79cd\u4eff\u5236\u836f\uff0c\u539f\u56e0\u662f\u4e34\u5e8a\u8bd5\u9a8c\u7684\u6570\u636e\u6709\u95ee\u9898\u3002\u4eca\u5e74\u5370\u5ea6\u836f\u54c1\u7684\u8d28\u91cf\u9891\u9891\u53d7\u5230\u8bd8\u95ee\uff0c\u76ee\u524d\u6b27\u6d32\u548c\u7f8e\u56fd\u7684\u76d1\u7ba1\u673a\u6784\u53d1\u73b0\u5370\u5ea6\u5236\u836f\u516c\u53f8\u7be1\u6539\u6570\u636e\u548c\u73af\u5883\u536b\u751f\u7b49\u95ee\u9898\u4e25\u91cd\uff0c\u8fd8\u7981\u6b62\u4e00\u4e9b\u4f01\u4e1a\u7684\u836f\u7269\u8fdb\u53e3\u3002<\/p>\n

\n

[hide for= “!logged”]<\/p>\n

\u5370\u5ea6\u8fd1\u65e5\u7684\u5236\u836f\u4ea7\u4e1a\u53ef\u8c13\u662f\u4e00\u6ce2\u672a\u5e73\uff0c\u4e00\u6ce2\u53c8\u8d77\u3002\u7ee7\u7f8e\u56fd\u3001\u5fb7\u56fd\u56e0\u751f\u4ea7\u95ee\u9898\u7981\u6b62\u5176\u6297\u751f\u7d20\u8fdb\u53e3\u4e4b\u540e\uff0c\u8fd1\u65e5\u6cd5\u56fd\u3001\u5fb7\u56fd\u3001\u6bd4\u5229\u65f6\u548c\u5362\u68ee\u5821\u53d6\u6d88\u6279\u51c6\u5370\u5ea6GVK Biosciences\u768425\u79cd\u4eff\u5236\u836f\uff0c\u539f\u56e0\u662f\u4e34\u5e8a\u8bd5\u9a8c\u7684\u6570\u636e\u6709\u95ee\u9898\u3002<\/p>\n

\u4eca\u5e74\u5370\u5ea6\u836f\u54c1\u7684\u8d28\u91cf\u9891\u9891\u53d7\u5230\u8bd8\u95ee\uff0c\u76ee\u524d\u6b27\u6d32\u548c\u7f8e\u56fd\u7684\u76d1\u7ba1\u673a\u6784\u53d1\u73b0\u5370\u5ea6\u5236\u836f\u516c\u53f8\u7be1\u6539\u6570\u636e\u548c\u73af\u5883\u536b\u751f\u7b49\u95ee\u9898\u4e25\u91cd\uff0c\u8fd8\u7981\u6b62\u4e00\u4e9b\u4f01\u4e1a\u7684\u836f\u7269\u8fdb\u53e3\u3002<\/p>\n

\u5c3d\u7ba1\u6cd5\u56fd\u7684\u836f\u54c1\u76d1\u7ba1\u90e8\u95e8ANSM\u4e5f\u627f\u8ba4\uff0c\u76ee\u524d\u8fd9\u4e9b\u63aa\u65bd\u53ea\u662f\u7528\u6765\u9632\u8303\u4e8e\u672a\u7136\uff0c\u5c3d\u7ba1\u6682\u65f6\u8fd8\u6ca1\u6709\u5bfc\u81f4\u4efb\u4f55\u5bf9\u4eba\u4f53\u4ea7\u751f\u5a01\u80c1\u6216\u662f\u5f71\u54cd\u836f\u6548\u7684\u4e8b\u4ef6\u53d1\u751f\uff0c\u4f46\u4f9d\u7136\u5fc5\u987b\u505a\u51fa\u51b3\u7b56\u3002\u76ee\u524d\u8fd9\u4e9b\u836f\u7269\u5168\u90e8\u505c\u6b62\u6279\u51c6\u901a\u8fc7\uff0c\u4e0d\u8fc7\u5176\u4e2d\u7531\u8fc8\u5170\u548c\u96c5\u57f9\u751f\u4ea7\u7684\u90e8\u5206\u836f\u54c1\u6709\u53ef\u66ff\u4ee3\u7684\u4ea7\u54c1\uff0c\u60a3\u8005\u4e0d\u9700\u8981\u4e2d\u65ad\u6cbb\u7597\u3002<\/p>\n

\u6cd5\u56fdANSM\u548c\u5fb7\u56fdBfArM\u4e24\u5927\u76d1\u7ba1\u673a\u6784\u58f0\u79f0\uff0c\u4ed6\u4eec\u6b63\u5728\u5bf9GVK\u57282008\u5e74\u81f32014\u5e74\u95f4\u63d0\u4f9b\u7684\u8bc1\u660e\u4eff\u5236\u836f\u4e0e\u539f\u4e13\u5229\u836f\u5177\u6709\u540c\u6837\u7597\u6548\u7684\u4e34\u5e8a\u8bd5\u9a8c\u6570\u636e\u8fdb\u884c\u91cd\u5ba1\u3002<\/p>\n

ANSM\u8868\u793a\uff0c\u6b27\u6d32\u76d1\u7ba1\u673a\u6784\u89c6\u5bdfGVK\u5728\u5370\u5ea6\u6d77\u5fb7\u62c9\u5df4\u5206\u90e8\u7684\u751f\u7269\u7b49\u6548\u6027\u7814\u7a76\u65f6\u53d1\u73b0\uff0c\u5fc3\u7535\u56fe\u7ed3\u679c\u4e2d\u5b58\u5728\u732b\u817b\uff0c\u4ece\u90a3\u4ee5\u540e\u6b27\u6d32\u76f8\u5173\u7684\u76d1\u7ba1\u673a\u6784\u5c31\u4ea7\u751f\u4e86\u8db3\u591f\u7684\u8b66\u89c9\uff0c\u4ed6\u4eec\u6000\u7591\u8be5\u516c\u53f8\u4e34\u5e8a\u8bd5\u9a8c\u5b58\u5728\u95ee\u9898\u3002<\/p>\n

\u4f4d\u4e8e\u4f26\u6566\u7684\u6b27\u6d32\u836f\u54c1\u7ba1\u7406\u5c40\uff08EMA\uff09\u72ec\u7acb\u53d1\u5e03\u4e86\u4e00\u5219\u58f0\u660e\uff0c\u5ba3\u5e03\u5c06\u4f1a\u5c31\u8fd9\u4e9b\u836f\u54c1\u5728\u6b27\u6d32\u7684\u5e02\u573a\u6388\u6743\u662f\u7ef4\u6301\u3001\u66f4\u6539\u3001\u6682\u505c\u8fd8\u662f\u5f7b\u5e95\u53d6\u6d88\u7684\u95ee\u9898\u4f5c\u51fa\u5efa\u8bae\uff0c\u8fd9\u9879\u5efa\u8bae\u9884\u671f\u4f1a\u57282015\u5e741\u6708\u4efd\u53d1\u5e03\u3002<\/p>\n

\u5fb7\u56fd\u7684\u76d1\u7ba1\u673a\u6784\u58f0\u660e\uff0c\u4ed6\u4eec\u8c03\u67e5\u4e86\u6388\u4e8828\u5bb6\u836f\u4f01\u7684176\u9879\u836f\u54c1\u6388\u6743\uff0c\u7136\u800c\u8be5\u673a\u6784\u5e76\u672a\u6307\u660e\u7a76\u7adf\u662f\u54ea\u4e9b\u4f01\u4e1a\u6216\u836f\u54c1\u53d7\u5230\u5f71\u54cd\uff0c\u4e5f\u672a\u7ed9\u51fa\u4f1a\u6709\u591a\u5c11\u6388\u6743\u53ef\u4ee5\u7ee7\u7eed\u4f7f\u7528\u3002<\/p>\n

\u5fb7\u56fdBfArM\u5ba3\u5e03\uff0c\u6d89\u4e8b\u836f\u4f01\u7684\u5ba1\u6279\u82e5\u662f\u5728GVK\u7684\u6570\u636e\u57fa\u7840\u4e0a\u901a\u8fc7\u7684\uff0c\u5df2\u88ab\u52d2\u4ee4\u505c\u6b62\u53d1\u552e\uff0c\u76f4\u5230\u4ed6\u4eec\u53ef\u4ee5\u4ece\u65b0\u7814\u7a76\u4e2d\u63d0\u4f9b\u6709\u6548\u6570\u636e\u3002<\/p>\n

ANSM\u6307\u51fa\uff0c\u6709\u4e00\u4e9b\u836f\u4f01\u5df2\u7ecf\u5f00\u59cb\u8fdb\u884c\u65b0\u7814\u7a76\uff0c\u82e5\u7ed3\u679c\u662f\u9633\u6027\uff0c\u5c31\u53ef\u4ee5\u7ee7\u7eed\u5141\u8bb8\u836f\u54c1\u9500\u552e\u3002<\/p>\n

\u7136\u800c\uff0cGVK \u81f3\u4eca\u672a\u5c31\u6b64\u4e8b\u505a\u51fa\u56de\u5e94\u3002<\/p>\n

\u7f51\u4e0a\u7684\u4e00\u5219\u58f0\u660e\u663e\u793a\uff0c\u6b27\u6d32\u836f\u54c1\u7ba1\u7406\u5c40\uff08EMA\uff09\u7684\u4eba\u7c7b\u7528\u836f\u4ea7\u54c1\u59d4\u5458\u4f1a\uff08CHMP\uff09\u53d1\u73b0\u6d77\u5fb7\u62c9\u5df4\u7684\u7814\u7a76\u6570\u636e\u4e0d\u8db3\u4ee5\u652f\u6301\u4ea7\u54c1\u5ba1\u6279\u3002EMA\u5e0c\u671b\u53d7\u5230\u5f71\u54cd\u7684\u836f\u4f01\u80fd\u591f\u5728\u63a5\u4e0b\u6765\u768412-15\u4e2a\u6708\u4e2d\u91cd\u590d\u76f8\u5173\u5b9e\u9a8c\u3002<\/p>\n

\u5370\u5ea6\u7684\u4eff\u5236\u836f\u4ee5\u4f4e\u4ef7\u83b7\u5f97\u7ade\u4e89\u4f18\u52bf\uff0c\u7136\u800c\u5728\u6b27\u7f8e\u5e02\u573a\u4e0a\uff0c\u4f4e\u4ef7\u82e5\u662f\u4ee5\u4f4e\u8d28\u4e3a\u4ee3\u4ef7\uff0c\u6574\u4e2a\u5370\u5ea6\u7684\u5236\u836f\u4ea7\u4e1a\u7ec8\u7a76\u90fd\u4f1a\u906d\u5230\u6c89\u91cd\u6253\u51fb\u3002<\/p>\n

[\/hide]<\/p>\n

\n","protected":false},"excerpt":{"rendered":"

Regulators in France, Germany, Belgium and Luxembourg are suspending the marketing approval of 25 generic drugs due to concerns over the quality of data from clinical trials conducted by India’s […]<\/p>\n","protected":false},"author":1001,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"c2c_always_allow_admin_comments":false,"footnotes":""},"categories":[2,5],"tags":[10,13,17],"class_list":["post-1346","post","type-post","status-publish","format-standard","hentry","category-government-news","category-pharmaceutical-company-news","tag-dispute","tag-drug-saftey","tag-government-supervision"],"_links":{"self":[{"href":"https:\/\/blog.rwth-aachen.de\/smartmedcn\/wp-json\/wp\/v2\/posts\/1346","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/blog.rwth-aachen.de\/smartmedcn\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/blog.rwth-aachen.de\/smartmedcn\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/blog.rwth-aachen.de\/smartmedcn\/wp-json\/wp\/v2\/users\/1001"}],"replies":[{"embeddable":true,"href":"https:\/\/blog.rwth-aachen.de\/smartmedcn\/wp-json\/wp\/v2\/comments?post=1346"}],"version-history":[{"count":0,"href":"https:\/\/blog.rwth-aachen.de\/smartmedcn\/wp-json\/wp\/v2\/posts\/1346\/revisions"}],"wp:attachment":[{"href":"https:\/\/blog.rwth-aachen.de\/smartmedcn\/wp-json\/wp\/v2\/media?parent=1346"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/blog.rwth-aachen.de\/smartmedcn\/wp-json\/wp\/v2\/categories?post=1346"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/blog.rwth-aachen.de\/smartmedcn\/wp-json\/wp\/v2\/tags?post=1346"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}